🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy and safety of venetoclax, chidamide, and chiglitaz...
Status
Recruiting
Location
the First affiliated hospital of xiamen university
Start Date
2026-11-11
Trial ID
NCT07783100
Treatments Being Tested
The purpose of the trial is to evaluate the effect of Chiglitazar added to ...
Status
Completed
Location
Hefei Second People's Hospital
Start Date
2021-07-06
Trial ID
NCT04807348
Treatments Being Tested
The study is to evaluate the efficacy and safety of chiglitazar monotherapy...
Status
Completed
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2022-03-21
Trial ID
NCT05193916
Treatments Being Tested
This multicenter, randomized, double-blind, placebo-controlled trial aims t...
Status
Not Yet Recruiting
Location
Quanzhou First Hospital, Fujian
Start Date
2026-04-18
Trial ID
NCT07558525
Treatments Being Tested
The goal of this clinical trial is to learn about inour study aimed to eval...
Status
Unknown
Location
Shanghai First People's Hospital
Start Date
2024-01-31
Trial ID
NCT06191328
Treatments Being Tested
The goal of this observational study is to evaluate the comprehensive clini...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-18
Trial ID
NCT07580638
Treatments Being Tested
To investigate the safety and efficacy of the CVA regimen, composed of Chig...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2025-03-15
Trial ID
NCT06737523
Treatments Being Tested
The goal of this clinical trial is to evaluate the Efficacy and Safety of C...
Status
Unknown
Location
the First Affiliated Hospital of Sun Yat-sen University
Start Date
2023-10-31
Trial ID
NCT06007014
Treatments Being Tested
Purpose and significance: To explore the clinical efficacy and safety of Ch...
Status
Unknown
Location
Gu Yunjuan
Start Date
2022-10-01
Trial ID
NCT05760677